COMPANY
Amryt Pharmaceuticals DAC
Amryt Pharmaceuticals DAC: marketing authorisation holder for Octreotide, as stated by public registers.
MARKETING AUTHORISATION HOLDER
Holds the licence to sell the medicine in a country (EMA, MHRA, Health Canada).
| Octreotide | Mycapssa (EMEA/H/C/005826), Withdrawn Regulator EMA |
|---|
What a register states, not an endorsement or an accusation by this site. All companies.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.